Ropeginterferon alfa-2b
A23-302
Phase 3 mab active
Quick answer
Ropeginterferon alfa-2b for Primary Myelofibrosis is a Phase 3 program (mab) at PharmaEssentia with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PharmaEssentia
- Indication
- Primary Myelofibrosis
- Phase
- Phase 3
- Modality
- mab
- Status
- active